Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis

Brain and Behavior

Volumn 6, Issue 9, 2016, Pages

  Marrie, Ruth Ann ^a   Patten, Scott B ^b   Greenfield, Jamie ^c   Svenson, Lawrence W ^b,d,e   Jette, Nathalie ^b,c,f   Tremlett, Helen ^g   Wolfson, Christina ^h   Warren, Sharon ^d   Profetto McGrath, Joanne ^d   Fisk, John D ⁱ   Blanchard, James ^e   Caetano, Patricia ^e   Elliott, Lawrence ^e   Yu, Bo Nancy ^e   Bhan, Virender ^e   Svenson, Larry ^e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e University of British Columbia ^*

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h MCGILL UNIVERSITY   (Canada)

ⁱ DALHOUSIE UNIVERSITY   (Canada)

Author keywords

administrative data; anxiety; comorbidity; depression; multiple sclerosis

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CHRONIC LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; EPILEPSY; FEMALE; FIBROMYALGIA; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATORY BOWEL DISEASE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; MULTIPLE SCLEROSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SOCIAL STATUS;

EID: 84978414603     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.493     Document Type: Article

References (36)

1. Buskila, D., L. Neumann, A. Alhoashle, and M. Abu-Shakra. 2000. Fibromyalgia syndrome in men. Semin. Arthritis Rheum. 30:47–51.
2. Chien, I. C., C. H. Lin, Y. J. Chou, and P. Chou. 2013. Increased risk of hyperlipidemia in patients with major depressive disorder: a population-based study. J. Psychosom. Res. 75:270–274.
3. Eaton, W. W., M. G. Pedersen, P. R. Nielsen, and P. B. Mortensen. 2010. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 12:638–646.
4. Egede, L. E. 2005. Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom. Med. 67:46–51.
5. Egede, L. E. 2007. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen. Hosp. Psychiatry 29:409–416.
6. Fahy, J. V. 2015. Type 2 inflammation in asthma–present in most, absent in many. Nat. Rev. Immunol. 15:57–65.
7. Feinstein, A., P. Roy, N. Lobaugh, K. Feinstein, P. O'Connor, and S. Black. 2004. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62:586–590.
8. Fromont, A., C. Binquet, F. Rollot, R. Despalins, A. Weill, L. Clerc, et al. 2013. Comorbidities at multiple sclerosis diagnosis. J. Neurol. 260:2629–2637.
9. Furtado, M., and M. A. Katzman. 2015. Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Res. 229:37–48.
10. Häuser, W., H. Kühn-Becker, H. von Wilmoswky, M. Settan, E. Brähler, and F. Petzke. 2011. Demographic and clinical features of patients with fibromyalgia syndrome of different settings: a gender comparison. Gend. Med. 8:116–125.
11. Hsu, C. C., S. C. Chen, C. J. Liu, T. Lu, C. C. Shen, Y. W. Hu, et al. 2014. Rheumatoid arthritis and the risk of bipolar disorder: a nationwide population-based study. PLoS One 9:e107512.
12. Janssens, K. A., W. L. Zijlema, M. L. Joustra, and J. G. Rosmalen. 2015. Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the lifelines cohort study. Psychosom. Med. 77:449–457.
13. Jensen, M. P., A. E. Smith, C. H. Bombardier, K. M. Yorkston, J. Miro, and I. R. Molton. 2014. Social support, depression, and physical disability: age and diagnostic group effects. Disabil. Health J. 7:164–172.
14. Lotrich, F. E., H. El-Gabalawy, L. C. Guenther, and C. F. Ware. 2011. The role of inflammation in the pathophysiology of depression: different treatments and their effects. J. Rheumatol. 88:48–54.
15. Marrie, R. A., G. Cutter, T. Tyry, D. Campagnolo, and T. Vollmer. 2009. Effect of physical comorbidities on risk of depression in multiple sclerosis. IJMSC 11:161–166.
16. Marrie, R. A., B. Yu, S. Leung, L. Elliott, P. Caetano, S. Warren, et al. 2012. Rising prevalence of vascular comorbidities in MS: validation of administrative definitions for diabetes, hypertension, hyperlipidemia. Mult. Scler. 18:1310–1319.
17. Marrie, R. A., B. N. Yu, S. Leung, L. Elliott, P. Caetano, S. Warren, et al. 2013a. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology 40:85–92.
18. Marrie, R. A., J. D. Fisk, B. N. Yu, S. Leung, L. Eillott, P. Caetano, et al. 2013b. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol. 13:16.
19. Marrie, R. A., B. N. Yu, S. Leung, L. Elliott, P. Caetano, S. Warren, et al. 2013c. Prevalence and incidence of ischemic heart disease in multiple sclerosis: a population-based validation study. Mult. Scler. Relat. Disord. 2:355–361.
20. Marrie, R. A., N. Reider, J. Cohen, O. Stuve, M. Trojano, P. S. Sorensen, et al. 2015a. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult. Scler. J. 21:263–281.
21. Marrie, R. A., L. Elliott, J. Marriott, M. Cossoy, A. Tennakoon, and N. Yu. 2015b. Comorbidity increases the risk of hospitalizations in multiple sclerosis. Neurology 84:350–358.
22. Marrie, R. A., L. Elliott, J. Marriott, M. Cossoy, J. Blanchard, S. Leung, et al. 2015c. Effect of comorbidity on mortality in multiple sclerosis. Neurology 85:240–247.
23. Marrie, R. A., J. D. Fisk, H. Tremlett, C. Wolfson, S. Warren, A. Tennakoon, et al. 2015d. Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology 85:1972–1979.
24. Mohr, D. C., D. E. Goodkin, W. Likosky, N. Gatto, K. A. Baumann, and R. A. Rudick. 1997. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch. Neurol. 54:531–533.
25. Patten, S. B. 2001. Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. J. Affect. Disord. 63:35–41.
26. Patten, S. B., C. A. Beck, J. V. A. Williams, C. Barbui, and L. M. Metz. 2003. Major depression in multiple sclerosis. Neurology 61:1524–1527.
27. Pettersson, E., H. Larsson, and P. Lichtenstein. 2015. Common psychiatric disorders share the same genetic origin: a multivariate sibling study of the Swedish population. Mol. Psychiatry 21:717–721.
28. Rosenblat, J. D., and R. S. McIntyre. 2015. Are medical comorbid conditions of bipolar disorder due to immune dysfunction? Acta Psychiatr. Scand. 132:180–191.
29. Severance, E. G., K. L. Gressitt, S. Yang, C. R. Stallings, A. E. Origoni, C. Vaughan, et al. 2014. Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord. 16:230–240.
30. Sin, D. D., S. B. Cohen, A. Day, H. Coxson, and P. D. Pare. 2007. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc. Am. Thorac. Soc. 4:671–674.
31. Spranger, J., A. Kroke, M. Möhlig, K. Hoffmann, M. M. Bergmann, M. Ristow, et al. 2003. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European prospective investigation into cancer and nutrition (EPIC)-potsdam study. Diabetes 52:812–817.
32. Steel, Z., C. Marnane, C. Iranpour, T. Chey, J. W. Jackson, V. Patel, and D. Silove 2014. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int. J. Epidemiol. 43:476–493.
33. Tellez-Zenteno, J. F., S. B. Patten, N. Jette, J. Williams, andS. Wiebe. 2007. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 48:2336–2344.
34. Weir, P. T., G. A. Harlan, F. L. Nkoy, S. S. Jones, K. T. Hegmann, L. H. Gren, et al. 2006. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J. Clin. Rheumatol. 12:124–128.
35. Wells, K. B., J. M. Golding, and M. A. Burnam. 1988. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am. J. Psychiatry 145:976–981.
36. Wu, E. L., I. C. Chien, C. H. Lin, Y. J. Chou, and P. Chou. 2012. Increased risk of hypertension in patients with major depressive disorder: a population-based study. J. Psychosom. Res. 73:169–174.